McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related produc… Read more
Market Cap & Net Worth: McKesson Corporation (MCK)
McKesson Corporation (NYSE:MCK) has a market capitalization of $115.54 Billion ($115.54 Billion) as of March 18, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #164 globally and #131 in its home market, demonstrating a 2.61% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying McKesson Corporation's stock price $943.25 by its total outstanding shares 122487456 (122.49 Million).
McKesson Corporation Market Cap History: 2015 to 2026
McKesson Corporation's market capitalization history from 2015 to 2026. Data shows growth from $22.47 Billion to $115.54 Billion (17.18% CAGR).
Index Memberships
McKesson Corporation is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$53.10 Trillion | 0.19% | #88 of 503 |
Weight: McKesson Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
McKesson Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how McKesson Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.28x
McKesson Corporation's market cap is 0.28 times its annual revenue
0.29x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
30.49x
McKesson Corporation's market cap is 30.49 times its annual earnings
9.22x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $16.11 Billion | $190.88 Billion | $2.26 Billion | 0.08x | 7.13x |
| 2017 | $18.03 Billion | $198.53 Billion | $5.18 Billion | 0.09x | 3.48x |
| 2018 | $12.91 Billion | $208.36 Billion | $67.00 Million | 0.06x | 192.70x |
| 2019 | $16.36 Billion | $214.32 Billion | $34.00 Million | 0.08x | 481.21x |
| 2020 | $20.79 Billion | $231.05 Billion | $900.00 Million | 0.09x | 23.10x |
| 2021 | $29.98 Billion | $238.23 Billion | -$4.54 Billion | 0.13x | N/A |
| 2022 | $45.52 Billion | $263.97 Billion | $1.11 Billion | 0.17x | 40.86x |
| 2023 | $56.51 Billion | $276.71 Billion | $3.56 Billion | 0.20x | 15.87x |
| 2024 | $69.81 Billion | $308.95 Billion | $3.00 Billion | 0.23x | 23.25x |
| 2025 | $100.48 Billion | $359.05 Billion | $3.29 Billion | 0.28x | 30.49x |
Competitor Companies of MCK by Market Capitalization
Companies near McKesson Corporation in the global market cap rankings as of March 18, 2026.
Key companies related to McKesson Corporation by market ranking:
- Cencora Inc. (NYSE:COR): Ranked #340 globally with a market cap of $64.39 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #428 globally with a market cap of $51.10 Billion USD.
- Sigma Healthcare Limited (OTCGREY:SIGGF): Ranked #1455 globally with a market cap of $12.16 Billion USD.
- SINOPHARM GROUP 1/5/O.N. (F:X2S1): Ranked #2100 globally with a market cap of $7.34 Billion USD ( €7.15 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #340 | Cencora Inc. | NYSE:COR | $64.39 Billion | $345.88 |
| #428 | Cardinal Health Inc | NYSE:CAH | $51.10 Billion | $217.59 |
| #1455 | Sigma Healthcare Limited | OTCGREY:SIGGF | $12.16 Billion | $1.88 |
| #2100 | SINOPHARM GROUP 1/5/O.N. | F:X2S1 | $7.34 Billion | €11.70 |
McKesson Corporation Historical Marketcap From 2015 to 2026
Between 2015 and today, McKesson Corporation's market cap moved from $22.47 Billion to $ 115.54 Billion, with a yearly change of 17.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $115.54 Billion | +14.99% |
| 2025 | $100.48 Billion | +43.93% |
| 2024 | $69.81 Billion | +23.53% |
| 2023 | $56.51 Billion | +24.13% |
| 2022 | $45.52 Billion | +51.83% |
| 2021 | $29.98 Billion | +44.23% |
| 2020 | $20.79 Billion | +27.06% |
| 2019 | $16.36 Billion | +26.72% |
| 2018 | $12.91 Billion | -28.40% |
| 2017 | $18.03 Billion | +11.95% |
| 2016 | $16.11 Billion | -28.30% |
| 2015 | $22.47 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of McKesson Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $115.54 Billion USD |
| MoneyControl | $115.54 Billion USD |
| MarketWatch | $115.54 Billion USD |
| marketcap.company | $115.54 Billion USD |
| Reuters | $115.54 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.